Karyopharm Therapeutics
KPTI
#9486
Rank
โ‚ฌ45.63 M
Marketcap
5,32ย โ‚ฌ
Share price
8.01%
Change (1 day)
418.27%
Change (1 year)

Revenue for Karyopharm Therapeutics (KPTI)

Revenue in 2024 (TTM): โ‚ฌ0.13 Billion

According to Karyopharm Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.12 Billion. an increase over the revenue in the year 2023 that were of โ‚ฌ0.13 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Karyopharm Therapeutics from 2013 to 2024

Annual revenue

Year Revenue Change
2024 โ‚ฌ0.13 B5.65%
2023 โ‚ฌ0.13 B-9.79%
2022 โ‚ฌ0.14 B-20.96%
2021 โ‚ฌ0.18 B110.83%
2020 โ‚ฌ87.87 M140.73%
2019 โ‚ฌ36.5 M37.66%
2018 โ‚ฌ26.51 M1882.38%
2017 โ‚ฌ1.33 M813.65%
2016 โ‚ฌ0.14 M-35.97%
2015 โ‚ฌ0.22 M21.96%
2014 โ‚ฌ0.18 M-33.1%
2013 โ‚ฌ0.28 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ56.28 B 44,081.58%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ41.78 B 32,698.80%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ36.79 B 28,783.82%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ1.90 B 1,393.22%๐Ÿ‡บ๐Ÿ‡ธ USA